loadpatents
Patent applications and USPTO patent grants for Spector; Neil Lee.The latest application filed is for "treatment of cancers expressing p95 erbb2".
Patent | Date |
---|---|
Treatment of Cancers Expressing p95 ErbB2 App 20150190397 - Spector; Neil Lee ;   et al. | 2015-07-09 |
Treatment of Cancers Expressing p95 ErbB2 App 20110020335 - Spector; Neil Lee ;   et al. | 2011-01-27 |
Treatment of cancers expressing p95 ErbB2 Grant 7,829,297 - Spector , et al. November 9, 2 | 2010-11-09 |
Predictive biomarkers in cancer therapy Grant 7,794,960 - Spector , et al. September 14, 2 | 2010-09-14 |
Treatment Of Cancers Expressing P95 Erbb2 App 20090192189 - Spector; Neil Lee ;   et al. | 2009-07-30 |
Predicitive biomarkers in cancer therapy App 20070190583 - Spector; Neil Lee ;   et al. | 2007-08-16 |
Biomarkers in cancer App 20070059785 - Bacus; Sarah S. ;   et al. | 2007-03-15 |
Treatment of cancers expressing p95 erbb2 App 20060204966 - Spector; Neil Lee ;   et al. | 2006-09-14 |
Cancer treatment method comprising administering an erb-family inhibitor and a raf and/or ras inhibitor App 20050176740 - Spector, Neil Lee ;   et al. | 2005-08-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.